Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders.
about
Dietary and botanical anxiolytics.The Effects of Magnesium Supplementation on Subjective Anxiety and Stress-A Systematic Review.Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic reviewComplementary medicine, exercise, meditation, diet, and lifestyle modification for anxiety disorders: a review of current evidence.Effects of traditionally used anxiolytic botanicals on enzymes of the gamma-aminobutyric acid (GABA) system.Effects of rhodiola crenulata on mice hearts under severe sleep apnea.Outcomes of self-help efforts in anxiety disorders.Effects in dogs with behavioural disorders of a commercial nutraceutical diet on stress and neuroendocrine parameters.Fixed dose-combination products in psychiatry: Systematic review and meta-analysis.Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.Modulatory Effects of Eschscholzia californica Alkaloids on Recombinant GABAA Receptors.Scientific Opinion on the substantiation of health claims related to magnesium and “hormonal health” (ID 243), reduction of tiredness and fatigue (ID 244), contribution to normal psychological functions (ID 245, 246), maintenance of normal blood g...Alkaloid profiling of herbal drugs using high resolution mass spectrometry.The Role of Magnesium in Neurological Disorders.Phenolic Composition and Antioxidant and Antimicrobial Activities of Extracts Obtained from Crataegus azarolus L. var. aronia (Willd.) Batt. Ovaries Calli
P2860
Q30455278-4C3B7DF5-4E92-4A23-9BA4-B28D7DC90359Q33749162-9390B03F-CDED-4484-9DC3-9D97E6D2D39DQ34221937-8387CBF7-8653-459A-9000-515D2ED3E9EDQ34411930-3DC0A873-D336-4A50-B766-4DA195220800Q34722740-3C2733D1-E341-4615-8DF3-79082C97B73CQ35673392-87C3993C-4769-4D0C-A90B-386C64725FA2Q37611809-E2C4041B-A8F2-4312-8C59-67A3161498D6Q37617046-924118C6-842D-41BA-8DC7-1C94E306BFA2Q38242634-B27FD0BD-6EBD-40B2-9482-31A82D29E16EQ38668992-0355D36C-6E33-4B1F-85AB-45211F70B5D0Q42066117-9F243F89-5C08-41C9-9983-184FB40B5954Q47148950-45ADD0EA-16A8-4B3F-BADE-733DE0E718E2Q48089390-517B7078-819C-4199-90B6-2117B1D01605Q55515107-582CFB47-1ADA-492E-B6AA-0479850DE937Q59053140-2DC4596D-CC5B-48B9-A53B-D44360541096
P2860
Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Double-blind, randomised, plac ...... to-moderate anxiety disorders.
@en
Double-blind, randomised, plac ...... to-moderate anxiety disorders.
@nl
type
label
Double-blind, randomised, plac ...... to-moderate anxiety disorders.
@en
Double-blind, randomised, plac ...... to-moderate anxiety disorders.
@nl
prefLabel
Double-blind, randomised, plac ...... to-moderate anxiety disorders.
@en
Double-blind, randomised, plac ...... to-moderate anxiety disorders.
@nl
P2093
P1476
Double-blind, randomised, plac ...... to-moderate anxiety disorders.
@en
P2093
Jacqueline Lafon
Marc Mathieu
Michel Hanus
P356
10.1185/030079903125002603
P407
P577
2004-01-01T00:00:00Z